Full text available by subscription ...
Subscribe
Keywords
fetal renin-angiotensin system blockade; candesartan; pulmonary hypoplasia
Key points
- Regular medication reviews should be undertaken for women of childbearing age.
- Neonatologists should ensure that a detailed maternal medication history is taken for all babies admitted to neonatal units.
- Fetal renin-angiotensin system blockade is a rare but potentially life-threatening condition. For those babies who do survive, neonatologists should ensure appropriate follow-up is put in place post-discharge.
